Ferritinophagy and Ferroptosis in the Management of Metabolic Diseases A Ajoolabady, H Aslkhodapasandhokmabad, P Libby, J Tuomilehto, ... Trends in Endocrinology & Metabolism, 2021 | 183 | 2021 |
Targeting Autophagy in Ischemic Stroke: from Molecular Mechanisms to Clinical Therapeutics A Ajoolabady, S Wang, G Kroemer, JM Penninger, VN Uversky, D Pratico, ... Pharmacology & Therapeutics, 2021 | 140 | 2021 |
Endoplasmic Reticulum Stress in Liver Diseases A Ajoolabady, N Kaplowitz, C Lebeaupin, G Kroemer, RJ Kaufman, ... Hepatology, 2023 | 109 | 2023 |
FUNDC1 Interacts with FBXL2 to Govern Mitochondrial Integrity and Cardiac Function through an IP3R3-Dependent Manner in Obesity J Ren, M Sun, H Zhou, A Ajoolabady, Y Zhou, J Tao, JR Sowers, Y Zhang Science Advances, 2020 | 93 | 2020 |
FUNDC1 Insufficiency Sensitizes High Fat Diet Intake-Induced Cardiac Remodeling and Contractile Anomaly through ACSL4-Mediated Ferroptosis Z Pei, Y Liu, S Liu, W Jin, Y Luo, M Sun, Y Duan, A Ajoolabady, J Sowers, ... Metabolism, 2021 | 90 | 2021 |
ER Stress and UPR in Alzheimer's Disease: Mechanisms, Pathogenesis, Treatment A Ajoolabady, D Lindholm, J Ren, D Pratico Cell Death & Disease - Nature, 2022 | 81 | 2022 |
Mitophagy Receptors and Mediators: Therapeutic Targets in the Management of Cardiovascular Ageing A Ajoolabady, H Aslkhodapasandhokmabad, A Aghanejad, Y Zhang, ... Ageing Research Reviews, 2020 | 76 | 2020 |
Mitophagy in Cardiovascular Diseases: Molecular Mechanisms, Pathogenesis, and Treatment A Ajoolabady, M Chiong, S Lavandero, DJ Klionsky, J Ren Trends in Molecular Medicine, 2022 | 66 | 2022 |
ER Stress in Obesity Pathogenesis and Management A Ajoolabady, S Liu, DJ Klionsky, GYH Lip, J Tuomilehto, S Kavalakatt, ... Trends in Pharmacological Sciences, 2022 | 60 | 2022 |
ER Stress in Cardiometabolic Diseases: from Molecular Mechanisms to Therapeutics A Ajoolabady, S Wang, G Kroemer, DJ Klionsky, VN Uversky, JR Sowers, ... Endocrine Reviews, 2021 | 48 | 2021 |
Enzyme-Based Autophagy in Anti-Neoplastic Management: from Molecular Mechanisms to Clinical Therapeutics A Ajoolabady, A Aghanejad, Y Bi, Y Zhang, H Aslkhodapasandhukmabad, ... BBA-Reviews on Cancer, 2020 | 48 | 2020 |
Inflammasome Signaling in Atrial Fibrillation: JACC State-of-the-Art Review A Ajoolabady, S Nattel, GYH Lip, J Ren Journal of the American College of Cardiology, 2022 | 46 | 2022 |
S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy N Rostami, A Nikkhoo, A Ajoolabady, G Azizi, M Hojjat-Farsangi, ... Molecular Diagnosis & Therapy, 2019 | 46 | 2019 |
Multifunctional Nanomedicines for Targeting Epidermal Growth Factor Receptor in Colorectal Cancer A Ajoolabady Cellular and Molecular Life Sciences, 2020 | 42* | 2020 |
Dysregulation of Iron Metabolism in Cardiovascular Diseases: From Iron Deficiency to Iron Overload Y Bi, A Ajoolabady, LJ Demillard, W Yu, ML Hilaire, Y Zhang, J Ren Biochemical Pharmacology, 2021 | 41 | 2021 |
Ferroptosis in Hepatocellular Carcinoma: Mechanisms and Targeted Therapy A Ajoolabady, D Tang, G Kroemer, J Ren British journal of cancer - Nature, 2023 | 38 | 2023 |
Nanomedicine for Improvement of Dendritic Cell-Based Cancer Immunotherapy V Hashemi, S Farhadi, MG Chaleshtari, B Seashore-Ludlow, A Masjedi, ... International Immunopharmacology, 2020 | 31 | 2020 |
FUNDC1 Interacts with GPX4 to Govern Hepatic Ferroptosis and Fibrotic Injury through a Mitophagy-Dependent Manner Y Bi, S Liu, X Qin, M Abudureyimu, L Wang, R Zou, A Ajoolabady, ... Journal of Advanced Research, 2024 | 29 | 2024 |
Chitosan-Based Nanotherapeutics for Ovarian Cancer Treatment L Alizadeh, A Zarebkohan, R Salehi, A Ajoolabady, M Rahmati-Yamchi Journal of Drug Targeting, 2019 | 29 | 2019 |
ER Stress and Inflammation Crosstalk in Obesity A Ajoolabady, C Lebeaupin, NN Wu, RJ Kaufman, J Ren Medicinal Research Reviews, 2023 | 28 | 2023 |